This discussion focused on gains made in the year following the ECHO trial results; the impact of COVID-19 on HIV and FP services and efforts to provide integrated SRH care; and what the future of HIV/SRH integration can and should look like. 

Panelists:

• Dr. Rachel Baggaley, World Health Organization (WHO), Geneva 
• Dr. Nyaradzo Mgodi, University of Zimbabwe-University of California, San Francisco (UZ-UCSF), Zimbabwe 
• Wame Jallow, International Treatment Preparedness Coalition (ITPC), Botswana
• Dr. Natasha Salifyanji Kaoma, CopperRose, Zambia

Moderated by: Beth Schlachter, Executive Director of FP2020 and Mitchell Warren, Executive Director of AVAC